COVID-19 and Gastrointestinal Disease: Current Insights and Future Management

• Eará dahkkit: Goyal, Hemant (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Fáttát: Medicine; COVID-19; liver; non-alcoholic steatohepatitis; transient elastography; mortality; liver disease; clinical manifestations; SARS-CoV-2; gastroenterology; hepatology; endoscopy; delivery of healthcare; acute mesenteric ischemia; thromboemboembolism; endothelitis; cytokines; hypercoagulability; inflammatory bowel disease; gastrointestinal manifestations; abdominal pain; dyspnea; clinical course; upper gastrointestinal bleeding; pandemic; outcomes; anxiety; depression; medication adherence; severity of COVID-19; hospitalized patients; risk factors; SARS-CoV-2 infection; gut dysbiosis; microbiota; gastrointestinal disorders; intestinal inflammation; ACE2 dysregulation; gut microbiota; enteric infection
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

COVID-19 is the most prominent and rapidly evolving public health concern in the world currently. The gastrointestinal manifestations of COVID-19 are increasingly being recognized. SARS-CoV-2 infection has been associated with the occurrence of nausea, vomiting, and diarrhea. SARS-CoV-2 has also bee...